• Oncology specialty physicians U.S. 2016 | Statistic

Health & Pharmaceuticals›
Physicians, Hospitals & Pharmacies›
Number of oncology specialty physicians in the U.S. 2016

Number of U.S. physicians in oncology specialties in 2016

	AMA's Masterfile Number (July 2016)	Medicare's Physician Compare Number (May 2016)
Medical oncology and/or hematology	14,639	12,136
Gynecologic oncology	506	984
Radiation oncology	4,921	4,441
Pediatric hematology/oncology*	2,560	-
Surgical oncology	469	897

© Statista 2017

Show further information

Show sources information

About This Statistic

This statistic displays the number of physicians in oncology in the United States by specialty based on two sources as of 2016. July 2016, the American Medical Association listed 506 physicians practicing gynecologic oncology in the country. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the United States.

Special Functions

Download as ...

Options

Global oncology revenue by top ten pharmaceutical companies 2016 and 2022

Global oncology revenue by top ten pharmaceutical companies 2016 and 2022

Global top pharmaceutical companies by oncology market share 2016 and 2022

Global top pharmaceutical companies by oncology market share 2016 and 2022

Deaths by cancer in the U.S. 1950-2015

Deaths by cancer in the U.S. 1950-2015

Top U.S. oncology products by revenue in 2016

Top U.S. oncology products by revenue in 2016

Top 5 worldwide oncology products by market share 2016 and 2022

Top 5 worldwide oncology products by market share 2016 and 2022

Statista Accounts: Access All Statistics. Starting from $588 / Year

Prices & Access

Statistics on "Oncology"

Cancer facts

The most important statistics

Leading causes of death worldwide in 2015 (in millions)Global death rate - leading causes 2015
Number of cancer deaths worldwide in 2015, by major type of cancerCancer deaths worldwide by major type 2015
Number of U.S. Americans with a history of cancer living between 2004 and 2016 (in millions)U.S. Americans with a history of cancer living 2004-2016
Number of new cancer cases in the United States from 1999 to 2013Number of new cancer cases in U.S. from 1999 to 2013
Deaths by cancer in the U.S. from 1950 to 2015 (per 100,000 population)*Deaths by cancer in the U.S. 1950-2015

Oncology market

The most important statistics

Global oncology costs from 2010 to 2016 (in billion U.S. dollars)*Global oncology costs 2010-2016
Projected growth and spending in oncology market globally from 2011 to 2021 (in billion U.S. dollars)Expenditure and growth worldwide in oncology market 2011-2021
Percentage of global oncology spending in 2010 and 2015, by regionShare of oncology market spending worldwide by region 2010 vs 2015
Global oncology spending in 2010, 2015, and 2020, by region (in billion U.S. dollars)*Oncology spending worldwide by region 2015 vs. 2020
Oncology spending in selected developed countries worldwide in 2015 (in billion U.S. dollars)*Oncology spending in selected developed countries 2015
Oncology spending as a percentage of total pharmaceutical spending in selected countries in 2015Oncology spending as share of pharmaceutical spending by country 2015

Companies

The most important statistics

Top 10 pharmaceutical companies based on global oncology revenue in 2016 and 2022 (in million U.S. dollars)*Global oncology revenue by top ten pharmaceutical companies 2016 and 2022
Top 10 pharmaceutical companies based on global oncology market share in 2016 and 2022*Global top pharmaceutical companies by oncology market share 2016 and 2022
Revenue distribution of Roche's Pharmaceuticals division from 2013 to 2016, by therapeutic area*Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2016
Percentage of Novartis AG's pharmaceutical revenue by therapy area in 2016*Percentage of Novartis pharmaceutical revenue by therapy area 2016
Revenue of Bristol-Myers Squibb by specialty from 2014 to 2016 (in million U.S. dollars)Bristol-Myers Squibb revenue by specialty
Venture investments in oncology companies in the U.S. from 2006 to 2016 (in million U.S. dollars)U.S. venture investments in oncology companies 2006-2016
Amount raised through initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2016 (in million U.S. dollars)*U.S. oncology company IPO money raised from 2006 to 2016

Cancer drugs

The most important statistics

Top 5 oncology products worldwide based on revenue in 2016 and 2022 (in million U.S. dollars)*Top 5 worldwide oncology products by revenue 2016 and 2022
Top 5 oncology products worldwide by market share in 2016 and 2022Top 5 worldwide oncology products by market share 2016 and 2022
Availability of new cancer drugs launched in 2011-2015 in selected countries as of 2016Availability of new cancer drugs by country as of 2016
Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)Top U.S. oncology products by revenue in 2016
Monthly costs of selected new cancer drugs as of 2016 (in U.S. dollars)*Monthly costs of select new cancer drugs 2016

Research and development

The most important statistics

Distribution of FDA breakthrough therapy requests by therapy area in 2016FDA on breakthrough therapy requests by therapy area 2016
Distribution of FDA breakthrough therapy requests granted by therapy area in 2016FDA on breakthrough therapy requests granted by therapy area 2016
Distribution of late phase oncology pipeline in 2006 and 2016, by typeDistribution of late phase oncology pipeline in 2016 by type
Time from NDA/BLA filings for new drugs to FDA approval in select disease areas in the U.S. between 2006 and 2015NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015
Number of cancer drugs in development in the United States from 2005 to 2015Number of cancer drugs in development in the U.S. 2005-2015
Probability of success for oncology vs non-oncology drugs in the U.S. in the different development phases from 2006 to 2015U.S. development Phase success rates for oncology and non oncology drugs 2006-2015
Five-year relative cancer survival rates in the U.S. in periods between 1975 and 2011, by ethnic group Cancer: 5-year survival rates in the U.S. by ethnic group 1975-2011
Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)*Leukemia survival rates prior and after introduction of Imatinib

Immuno-oncology

The most important statistics

Distribution of cancer immunotherapies worldwide by technology as of 2015Distribution of cancer immunotherapies by technology 2015
Global cancer immunotherapy sales in 2014 and projection for 2021 (in billion U.S. dollars)Global cancer immunotherapy sales 2014 and 2021 forecast
Global cancer immunotherapy sales distribution in 2014 and projection for 2021, by typeGlobal cancer immunotherapy sales share by type 2014 and 2021 forecast
Number of cancer immunotherapy companies worldwide by country of origin as of 2015Number of cancer immunotherapy companies by country of origin 2015
Market share forecast for top immuno-oncology companies worldwide in 2021*Global cancer immunotherapy sales share by type 2021 forecast

Treatment types

The most important statistics

Distribution of treatment types for female breast cancer in the U.S. in 2013, by stageDistribution of treatment types for female breast cancer by stage 2013
Distribution of treatment types for prostate cancer in the U.S. in 2010-2012Distribution of treatment types for prostate cancer 2010-2012
Distribution of treatment types for colon cancer in the U.S. in 2013, by stageDistribution of treatment types for colon cancer by stage 2013
Distribution of treatment types for lung cancer in the U.S. in 2013*Distribution of treatment types for lung cancer in the U.S. 2013
Distribution of treatment types for non-Hodgkin lymphoma in the U.S. in 2013Distribution of treatment types for non-Hodgkin lymphoma 2013

Physicians and patients

The most important statistics

Number of U.S. physicians in oncology specialties in 2016Number of oncology specialty physicians in the U.S. 2016
Share of U.S. oncology practices by size and setting of practice in 2015Disbtribution of U.S. oncology practices by size and setting 2015
Hours per week that oncologists in the U.S. spend seeing patients as of 2016Number of hours U.S. oncologists spend a week seeing patients 2016
Minutes that oncologists in the U.S. spend with each patient as of 2016, by genderNumber of minutes U.S. oncologists spend with each patient 2016, by gender
Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2014 (in days)Inpatient average length of stay in U.S. hospitals by cancer type 2008-2014
Percentage of oncology patients in the U.S. who had used complementary or integrative health approaches in the past year as of 2015, by typeU.S. cancer patients who used complementary or alternative medicine 2015, by type

Related Studies: Available to Download in PDF or PPTX Format

Oncology

All Information
in one Presentation

Oncology

109 page/s
English
pptx
Detailed references

Everything On "Oncology" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers

Physicians in the U.S.

Statista for Your Company: The Research and Analysis Tool

Product Film
Statistics
Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Google

Samsung

Unilever

Procter and Gamble

Adobe

Telekom

PayPal

Otto

Further Content: Statistics, Studies, and Topic Pages

Statistics

Topics

Studies

Our Business Solutions: Save Time and Money

only

$588^*

per year

Your advantages

Full access to all our statistics
Download as XLS, PDF & PNG
Relevant data: complete source information

All functions of our platform illustrated face-to-face

Learn how Statista supports your company
Extensive tour across the whole portal
Personal guidance by our support team

Request webinar

The knowledge database for your company

All functions of the Premium Account
Access to dossiers, forecasts and studies
Access to our international database
Publishing rights and other exclusive functions

* All products require an annual contract.
Prices do not include sales tax
(New York residents only).

	Basic Account	Instant Access Premium Account
Our services Click the question mark for further information	Free	$49 per month* (billed annually)
Basic statistics
Premium statistics

Graph download
Download PDF
Excel download
	Register	Purchase now

*Duration: 12 months, billed annually, single license